Borderline Hypertension: Clinical and Pathophysiologic Significance

  • Stevo Julius
Conference paper
Part of the Ergebnisse der Inneren Medizin und Kinderheilkunde / Advances in Internal Medicine and Pediatrics book series (KINDERHEILK. NF, volume 41)


Borderline hypertension can best be characterized as a condition where a subject’s blood pressure is above the normal range, but is not sufficiently elevated to warrant immediate treatment. This “gray zone” between normotension and hypertension has been defined in many ways by various authors and health organizations. For the purpose of this review we will define normal blood pressure and clearly hypertensive readings and then designate as borderline hypertension readings that fall between the normal and hypertensive limits (Table 1). Age of the individual is also taken into consideration.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Alameda County Blood Pressure Study, State of California Department of Public Health; Berkeley 1968Google Scholar
  2. Bello, C.T., Sevy, R.W., Harakal, C., et al.: Relationship between clinical severity of disease and hemodynamic patterns in essential hypertension. Amer. J. Med. 253, 194–208 (1967)Google Scholar
  3. Birkenhäger, W.H., Schalekamp, M.A.D.H., Krauss, X.H., Kolsters, G., Zaal, G.A.: Consecutive haemodynamic patterns in essential hypertension. Lancet 1972 I, 560–564Google Scholar
  4. Bøe, J., Humerfelt, S., Wedervang, F.: The blood pressure in a population: Blood pressure readings and height and weight determinations in the adult population of the city of Bergen. Acta Med. Scand. Suppl. 321, 1–336 (1957)PubMedGoogle Scholar
  5. Boynton, R.E., Todd, R.L.: Blood pressure readings of 75,258 university students. Arch. Intern. Med. 80, 454–462 (1947)Google Scholar
  6. Brunner, H.R., Laragh, J.H., Baer, L., et al.: Essential hypertension: renin and aldosterone, heart attack and stroke. N. Engl. J. Med. 286, 441–449 (1972)PubMedGoogle Scholar
  7. Cohen, D.H., Obrist, P.A.: Interactions between behavior and the cardiovascular system. Circ. Res. 37, 693–706 (1975)PubMedGoogle Scholar
  8. Cowley, A.W., Jr., Liard, J.F., Guyton, A.C.: Role of the baroreceptor reflex in daily control of arterial blood pressure and other variables in dogs. Circ. Res. 32, 564–576 (1973)PubMedGoogle Scholar
  9. De Quattro, V., Chan, S.: Raised plasma catecholamines in some patients with primary hypertension. Lancet 1972 I, 806–809Google Scholar
  10. Eich, R.H., Jacobsen, E.D.: Vascular reactivity in medical students followed for 10 years. J. Chronic Dis. 20, 583–592 (1967)PubMedGoogle Scholar
  11. Eich, R.H., Cuddy, R.P., Smulyan, H., et al.: Hemodynamics in labile hypertension: A follow-up study. Circulation 34, 299–307 (1966)PubMedGoogle Scholar
  12. Eich, R.H., Peters, R.J., Cuddy, R.P., et al.: The hemodynamics in labile hypertension. Amer. Heart J. 63, 188–195 (1962)PubMedGoogle Scholar
  13. Ellis, C.N., Julius, S.: Role of central blood volume in hyperkinetic borderline hypertension. Br. Heart J. 35, 450–455 (1973)PubMedGoogle Scholar
  14. Esler, M.D., Nestel, P.J.: Renin and sympathetic nervous system responsiveness to adrenergic stimuli in essential hypertension. Amer. J. Cardiol. 32, 643–649 (1973a)PubMedGoogle Scholar
  15. Esler, M.D., Nestel, P.J.: Sympathetic responsiveness to head-up tilt in essential hypertension. Clin. Sci. 44, 213–226 (1973b)PubMedGoogle Scholar
  16. Esler, M.D., Julius, S., Randall, O.S., Ellis, C.N., Kashima, T.: Relation of renin status to neurogenic vascular resistance in borderline hypertension. Amer. J. Cardiol. 36, 708–715 (1975)PubMedGoogle Scholar
  17. Esler, M., Julius, S., Randall, O.: Relationship of volume factors, renin and neurogenic vascular resistance in borderline hypertension. In: The Arterial Hypertensive Disease — A Symposium. Rorive, G., Van Cauwenberge, H. (Eds.). Paris: Masson 1976a, pp. 231–249Google Scholar
  18. Esler, M.D., Julius, S., Randall, O., Kashima, T.: Renin and indices of neurogenic activity in borderline hypertension. In: The Nervous System in Arterial Hypertension. Julius, S., Esler, M. (Eds.). Springfield, Ill.: Thomas 1976b, pp. 331–354Google Scholar
  19. Esler, M., Zweifler, A., Randall, O., Julius, S., Bennett, J., Rydelek, P.: Suppression of sympathetic nervous function in low-renin essential hypertension. Lancet 1976c II, 115–118Google Scholar
  20. Esler, M., Julius, S., Zweifler, A., Randall, O., Harburg, E., Gardiner, H., De Quattro, V.: Mild high-renin essential hypertension. Neurogenic human hypertension? N. Engl. J. Med. 296, 405–411 (1977)PubMedGoogle Scholar
  21. Evans, W.: Hypertonia or uneventful high blood pressure. Lancet 1957 II, 53–59Google Scholar
  22. Finkielman, S., Worcel, M., Agrest, A.: Hemodynamic patterns in essential hypertension. Circulation 31, 356–368 (1965)PubMedGoogle Scholar
  23. Folkow, B., Rubinstein, E.H.: Cardiovascular effects of acute and chronic stimulation of the hypothalamic defense area in the rat. Acta Physiol. Scand. 68, 48–57 (1966)Google Scholar
  24. Freis, E.D.: Salt, volume and the prevention of hypertension. Circulation 53, 589–595 (1976)PubMedGoogle Scholar
  25. Frohlich, E.D., Kozul, V.J., Tarazi, R.C., et al.: Physiological comparison of labile and essential hypertension. Circ. Res. 46 (Suppl. I), 55–69 (1970)Google Scholar
  26. Frohlich, E.D., Tarazi, R.C., Dustan, H.P.: Hyperdynamic beta-adrenergic circulatory state: increased beta-receptor responsiveness. Arch. Intern. Med. 123, 1–7 (1969)PubMedGoogle Scholar
  27. Fröhlich, E.D., Tarazi, R.C., Ulrych, M., et al.: Tilt test for investigating a neural component in hypertension. Circulation 36, 387–393 (1967)PubMedGoogle Scholar
  28. Geffen, L.B., Rush, R.A., Louis, W.J., et al.: Plasma dopamine-β-hydroxylase and noradrenaline amounts in essential hypertension. Clin. Sci. 44, 617–620 (1973)PubMedGoogle Scholar
  29. Gribbin, B., Pickering, T.G., Sleight, P., et al.: Effect of age and high blood pressure on baroreflex sensitivity in man. Circ. Res. 29, 424–430 (1971)PubMedGoogle Scholar
  30. Guyton, A.C., Coleman, T.G.: Quantitative analysis of the pathophysiology of hypertension. Circ. Res. 24–25 (Suppl. I), 1–19 (1969)Google Scholar
  31. Hamet, P., Kuchel, O., Genest, J.: Effect of upright posture and isoproterenol infusion on cyclic adenosine monophosphate excretion in control subjects and patients with labile hypertension. J. Clin. Endocrinol. Metab. 36, 218–226 (1973)PubMedGoogle Scholar
  32. Harburg, E., Julius, S., McGinn, N.F., McLeod, J., Hoobler, S.W.: Personality traits and behavioral patterns associated with systolic blood pressure levels in college males. J. Chronic Dis. 17, 405–414 (1964)PubMedGoogle Scholar
  33. Harlan, W.R., Jr., Osborne, R.K., Graybiel, A.: Prognostic value of the cold pressor test and the basal blood pressure: Based on an 18 year follow-up study. Amer. J. Cardiol. 13, 683–687 (1964)PubMedGoogle Scholar
  34. Harris, R.E., Sokolow, M., Carpenter, L.G., et al.: Response to psychologic stress in persons who are potentially hypertensive. Circulation 7, 874–879 (1953)PubMedGoogle Scholar
  35. Heyden, S., Bartel, A.G., Harnes, CG., et al.: Elevated blood pressure levels in adolescents, Evans County, Georgia: 7-year followup of 30 patients and 30 controls. JAMA 209, 1683–1689 (1969)PubMedGoogle Scholar
  36. Hines, E.A., Jr.: Vascular reactivity and hypertensive disease. Coll. Papers Mayo Clin. 42, 317–325 (1950)Google Scholar
  37. Horwitz, D., Alexander, R.W., Lovenberg, W., et al.: Human serum dopamine-β-hydroxylase. Relationship to hypertension and sympathetic activity. Circ. Res. 32, 594–599 (1973)PubMedGoogle Scholar
  38. Julius, S.: Abnormalities of autonomic nervous control in borderline hypertension. Schweiz. Med. Wschr. 106, 1698–1705 (1976)PubMedGoogle Scholar
  39. Julius, S.: Borderline hypertension. An overview. Med. Clin. North Amer. 61, 495–511 (1977)Google Scholar
  40. Julius, S., Conway, J.: Hemodynamic studies in patients with borderline blood pressure elevation. Circulation 38, 272–288 (1968)Google Scholar
  41. Julius, S., Esler, M.: Autonomic nervous cardiovascular regulation in borderline hypertension. Amer. J. Cardiol. 36, 685–696 (1975)PubMedGoogle Scholar
  42. Julius, S., Esler, M.: Increased central blood volume: A possible pathophysiological factor in mild low-renin essential hypertension. Clin. Sci. Mol. Med. 51 (Suppl. 3), 207s–210s (1976)Google Scholar
  43. Julius, S., Esler, M.: Patterns of neurogenic involvement in borderline and essential hypertension. In: Progress in Brain Research, Hypertension and Brain Mechanisms. DeJong, W., Provoost, A.P., Shapiro, A.P. (Eds.) Elsevier Series, Vol. 47, pp. 251–262. New York: Elsevier 1977Google Scholar
  44. Julius, S., Hansson, L.: Hemodynamics of prehypertension and hypertension. Verh. Dtsch. Ges. Inn. Med. 80, 49–58 (1974)PubMedGoogle Scholar
  45. Julius, S., Schork, M.A.: Borderline hypertension. A critical review. J. Chronic Dis. 23, 723–754 (1971)PubMedGoogle Scholar
  46. Julius, S., Schork, M.A.: Prediction of hypertension. Proc. N.Y. Acad. Sci. 304, 38 (1978)Google Scholar
  47. Julius, S., Stewart, B.H.: Diagnostic significance of abdominal murmurs. N. Engl. J. Med. 276, 1175–1178 (1967)PubMedGoogle Scholar
  48. Julius, S., Ellis, C.N., Pascual, A.V., Matice, M., Hansson, L., Hunyor, S.N., Sandler, L.N.: Home blood pressure determinations: value in borderline (“labile”) hypertension. JAMA 229, 663–666 (1974a)PubMedGoogle Scholar
  49. Julius, S., Esler, M.D., Randall, O.S., Elks, C.N.: Neurogenic maintenance of peripheral resistance in borderline hypertension. Acta Physiol. Lat. Am. 24, 425–431 (1974b)PubMedGoogle Scholar
  50. Julius, S., Esler, M.D., Randall, O.S.: Role of the autonomic nervous system in mild human hypertension. Clin. Sci. Mol. Med. 48, 243s–252s (1975a)Google Scholar
  51. Julius, S., Randall, O.S., Esler, M.D., Kashima, T., Ellis, C.N., Bennett, J.: Altered cardiac responsiveness and regulation in the normal cardiac output type of borderline hypertension. Circ. Res. 36–37 (Suppl. I), I-199–I-207 (1975b)Google Scholar
  52. Julius, S., Esler, M., Hansson, L., Zweifler, A.J.: Dissociation of the renin lowering and antihypertensive actions of propranolol. In: Advances in Clinical Pharmacology, Beta-Blocker in der Hypertonie-Behandlung. Hitzenberger, G. (Ed.), Vol. 11, pp. 33–41. München: Urban & Schwarzenberg 1976Google Scholar
  53. Julius, S., Harburg, E., McGinn, N.F., Keyes, J., Hoobler, S.W.: Relation between causal blood pressure readings in youth and at age 40: A retrospective study. J. Chronic Dis. 17, 397–404 (1964)PubMedGoogle Scholar
  54. Julius, S., Pascual, A.V., London, R.: Role of parasympathetic inhibition in the hyperkinetic type of borderline hypertension. Circulation 44, 413–418 (1971a)PubMedGoogle Scholar
  55. Julius, S., Pascual, A.V., Reilly, K., London, R.: Abnormalities of plasma volume in borderline hypertension. Arch. Intern. Med. 127, 116–119 (1971b)PubMedGoogle Scholar
  56. Julius, S., Pascual, A.V., Sannerstedt, R., Mitchell, C.: Relationship between cardiac output and peripheral resistance in borderline hypertension. Circulation 43, 382–390 (1971c)PubMedGoogle Scholar
  57. Julius, S., Sannerstedt, R., Conway, J.: Hemodynamic effects of propranolol in borderline hypertension (abstract). Circulation 38 (Suppl. 6), 109 (1968)Google Scholar
  58. Kannel, W.B.: Importance of hypertension as a major risk factor in cardiovascular disease. In: Hypertension. Genest, J., Koiw, E., Kuchel, O. (Eds.) New York: McGraw-Hill 1977, pp. 888–910Google Scholar
  59. Kannel, W.B., Schwartz, M.J., McNamara, P.M.: Blood pressure and risk of coronary heart disease: The Framingham study. Dis. Chest. 56, 43–52 (1969)PubMedGoogle Scholar
  60. Kooperstein, S.I., Schifrin, A., Leahy, T.J.: Level of initial blood pressure and subsequent development of essential hypertension: A 10 and 15 year followup study. Am. J. Cardiol. 10, 416–423 (1962)PubMedGoogle Scholar
  61. Korner, P.I., West, M.J., Shaw, J., et al.: “Steady state” properties of the baroreceptorheart rate reflex in essential hypertension in man. Clin. Exp. Pharmacol. Physiol. 1, 65–76 (1974)PubMedGoogle Scholar
  62. Kuschke, H.J.: Investigations about the state of excitation of the sympathetic nervous system and of the adrenal medulla in cardiovascular diseases. Arch. Kreislaufforsch. 36, 104–148 (1961)PubMedGoogle Scholar
  63. Levy, R.L., Hillman, C.C., Stroud, W.D., et al.: Transient hypertension: Its significance in terms of later development of sustained hypertension and cardiovascular-renal diseases. JAMA 126, 829–833 (1944)Google Scholar
  64. Levy, R.L., White, P.D., Stroud, W.D., et al.: Transient tachycardia: Prognostic significance alone and in association with transient hypertension. JAMA 129, 585–588 (1945)Google Scholar
  65. Lew, E.A.: Blood pressure and mortality—Life insurance experience. In: The Epidemiology of Hypertension: Proceedings of an International Symposium. Stamler, J., Stamler, R., Pullman, T.N. (Eds.). New York:Grune & Stratton 1967, pp. 392–397Google Scholar
  66. Louis, W.J., Doyle, A.E., Anavekar, S.: Plasma norepinephrine levels in essential hypertension. N. Engl. J. Med. 288, 599–601 (1973)PubMedGoogle Scholar
  67. Lund-Johansen, P.: Hemodynamics in early essential hypertension. Acta Med. Scand. 482 (Suppl.), 1–105 (1967)Google Scholar
  68. Mark, A.L., Lawton, W.J., Abboud, F.M., Fitz, A.E., Connor, W.E., Heistad, D.D.: Effects of high and low sodium intake on arterial pressure and forearm vascular resistance in borderline hypertension. Circ. Res. 36–37 (Suppl. I), I-194–I-198 (1975)Google Scholar
  69. Mathewson, F.A., Brereton, C.C., Keltie, W.A., et al.: The University of Manitoba followup study: A prospective investigation of cardiovascular disease — II. Build, blood pressure and electrocardiographic factors possibly associated with the development of coronary heart disease. Canad. Med. Ass. J. 92, 1002–1006 (1965)PubMedGoogle Scholar
  70. Mathewson, F.A.: Blood pressure in Canadian aviators: A fifteenth year report. Trans. Assoc. Life Ins. Med. Dir. 50, 218–226 (1966)Google Scholar
  71. McCubbin, J.W., Green, J.H., Page, I.H.: Baroreceptor function in chronic renal hypertension. Circ. Res. 4, 205–210 (1956)PubMedGoogle Scholar
  72. McGinn, N.F., Harburg, E., Julius, S.: Blood pressure reactivity and recall of treatment by parents. J. Pers. Soc. Psychol. 1, 147–153 (1965)Google Scholar
  73. Miettinen, M., Turpeinen, O., Karvonen, M.J., et al.: Effect of cholesterol-lowering diet on mortality from coronary heart-disease and other causes. A twelve-year clinical trial in men and women. Lancet 1972 II, 835–838Google Scholar
  74. Musgrave, F.S., Zechman, F.W., Mains, R.C.: Comparison of the effects of 70° tilt and several levels of lower body negative pressure on heart rate and blood pressure in man. Aerospace Med. 42, 1065–1069 (1971)PubMedGoogle Scholar
  75. National Health Survey: Vital and Health Statistics. Blood pressure of persons 18–74 years. United States, 1971–72. Series 11, Number 150Google Scholar
  76. Nestel, P.J.: Blood pressure and catecholamine excretion after mental stress in labile hypertension. Lancet 1969 I, 692–694Google Scholar
  77. Nestel, P.J., Doyle, A.E.: The excretion of free noradrenaline and adrenaline by healthy young subjects and by patients with essential hypertension. Aust. Ann. Med. 17, 295–299 (1968)PubMedGoogle Scholar
  78. Öberg, B., Thorén, P.: Circulatory responses to stimulation of left ventricular receptors in the cat. Acta Physiol. Scand. 83, 8–22 (1973)Google Scholar
  79. Ogihara, T., Nugent, C.A.: Serum DBH in three forms of acute stress. Life Sci. 15, 923–930 (1974)PubMedGoogle Scholar
  80. Ostfeld, A.M., Paul, O.: The inheritance of hypertension. Lancet 1963 I, 575–579Google Scholar
  81. Paffenbarger, R.S., Jr., Thorne, M.C., Wing, A.L.: Chronic disease in former college student — VIII. Characterisitcs in youth predisposing to hypertension in later years. Am. J. Epidemiol. 88, 25–32 (1968)PubMedGoogle Scholar
  82. Pelletier, C.L., Shepherd, J.T.: Circulatory reflexes from mechanoreceptors in the cardio-aortic area. Circ. Res. 33, 131–138 (1973)PubMedGoogle Scholar
  83. Reisin, E., Abel, R., Modan, M., Süverberg, D.S., Eliahou, H.E., Modan, B.: Effect of weight loss without salt restriction on the reduction of blood pressure in overweight hypertensive patients. N. Engl. J. Med. 298, 1–6 (1978)PubMedGoogle Scholar
  84. Rothlin, E., Cerletti, A., Emmenegger, R.: Experimental psychoneurogenic hypertension and its treatment with hydrogenated ergot alkaloids (hydergine). Acta Med. Scand. 154 (Suppl. 312), 27–35 (1956)Google Scholar
  85. Safar, M.E., Weiss, Y.A., Levenson, J.A., et al.: Hemodynamic study of 85 patients with borderline hypertension. Am. J. Cardiol. 31, 315–319 (1973)PubMedGoogle Scholar
  86. Sannerstedt, R.: Hemodynamic response to exercise in patients with arterial hypertension. Acta Med. Scand. Suppl. 458, 1–83 (1966)PubMedGoogle Scholar
  87. Sannerstedt, R., Julius, S.: Systemic haemodynamics in borderline arterial hypertension: Response to static exercise before and under the influence of propranolol. Cardiovasc. Res. 6, 398–403 (1972)PubMedGoogle Scholar
  88. Shapiro, A.P., Schwartz, G.E., Ferguson, D.C.E., Redmond, D.P., Weiss, S.M.: Behavioral methods in the treatment of hypertension. A review of their clinical status. Ann. Intern. Med. 86, 626–636 (1977)Google Scholar
  89. Simon, G., Pamnani, M.B., Overbeck, H.W.: Decreased venous compliance in dogs with chronic renal hypertension. Proc. Soc. Exp. Biol. Med. 152, 122–125 (1976)PubMedGoogle Scholar
  90. Sivertsson, R.: The hemodynamic importance of structural vascular changes in essential hypertension. Acta Physiol. Scand. 79 (Suppl. 343), 3–56 (1970)Google Scholar
  91. Sokolow, M., Wedegar, D., Kain, H.K., et al.: Relationship between level of blood pressure measured casually and by portable recorder, and severity of complications in essential hypertension. Circulation 34, 279–298 (1966)PubMedGoogle Scholar
  92. Stamler, J., Berkson, D.M., Dyer, A. et al.: Relationship of multiple variables to blood pressure. In: Epidemiology and Control of Hypertension. Paul, O. (Ed.). Miami: Symposia Specialists, 1975, p. 307Google Scholar
  93. Stamler, J., Lindberg, H.A., Berkson, D.M., et al.: Epidemiological analysis of hypertension and hypertensive disease in the labor force of a Chicago utility company. Proc. Coun. High Blood Press. Res. 7, 23–52 (1958)Google Scholar
  94. Stone, R.A., Gunnels, J.C., Robinson, R.R., et al.: Dopamine-β-hydroxylase in primary and secondary hypertension. Circ. Res. 22 (Suppl. I), 47–56 (1974)Google Scholar
  95. Suck, A.F., Mendlowitz, M., Wolf, R.L., et al.: Identification of essential hypertension in patients with labile blood pressure. Chest 59, 402–406 (1971)PubMedGoogle Scholar
  96. Takeshita, A., Tanaka, S., Kuroiwa, A., et al.: Reduced baroreceptor sensitivity in borderline hypertension. Circulation 51, 738–742 (1975)PubMedGoogle Scholar
  97. Tarazi, R.C., Dustan, H.P.: Beta-adrenergic blockade in hypertension. Practical and theoretical implications of long-term hemodynamic variations. Am. J. Cardiol. 29, 633–639 (1972)PubMedGoogle Scholar
  98. Tarazi, R.C., Frohlich, E.D., Dustan, H.P.: Plasma volume in men with essential hypertension. N. Engl. J. Med. 278, 762–765 (1968)PubMedGoogle Scholar
  99. Tarazi, R.C., Ibrahim, M.M., Dustan, H.P., et al.: Cardiac factors in hypertension. Circ. Res. 34–35 (Suppl. I), I-213–I-243 (1974)Google Scholar
  100. Thomas, C.B.: Developmental patterns in hypertensive cardiovascular disease: Fact or fiction? Bull. N.Y. Acad. Med. 45, 831–850 (1969)PubMedGoogle Scholar
  101. Thomas, CG., Ross, D.C., Higgenbottom, C.Q.: Precursors of hypertension and coronary disease among healthy medical students. Discriminant function analysis. II. Using parental history as the criterion. Bull. Johns Hopkins Hosp. 115, 245–264 (1964)PubMedGoogle Scholar
  102. Thomas, C.B., Stanley, J.A., Kendrick, M.A.: Observations on some possible precursors of essential hypertension and coronary artery disease — VII. The subjective reaction to the cold pressor test as expressed in the verbal response. J. Chronic Dis. 14, 355–365 (1961)PubMedGoogle Scholar
  103. Thomson, K.J.: Some observations on the development and course of hypertensive vascular disease. Proc. Annu. Meet. Med. Sect. Am. Life Convention 38, 85–112 (1950)Google Scholar
  104. Veterans Administration Cooperative Study Group on Antihypertensive Agents: Effect of treatment on morbidity in hypertension. JAMA 202, 1028–1034 (1967)Google Scholar
  105. Veterans Administration Cooperative Study Group on Antihypertensive Agents: Effects of treatment on morbidity in hypertension. II. Results in patients with diastolic blood pressure averaging 90–114 mm Hg. JAMA 213, 1143–1152 (1970)Google Scholar
  106. Walsh, J.A., Hyman, C., Maronde, R.F.: Venous distensibility in essential hypertension. Cardiovasc. Res. 3, 338–349 (1969)PubMedGoogle Scholar
  107. Weinshilboum, R.M., Raymond, F.A., Elveback, L.R.: Serum dopamine-β-hydroxylase activity: sibling-sibling correlation. Science 181, 943–945 (1973)PubMedGoogle Scholar
  108. Wetterberg, L., Aberg, H., Ross, S.B., et al.: Plasma dopamine-β-hydroxylase activity in hypertension and various neuropsychiatrie disorders. Scand. J. Clin. Lab. Invest. 30, 283–289 (1972)PubMedGoogle Scholar
  109. Wezler, K., Böger, A.: Die Dynamik des arteriellen Systems. Der arterielle Blutdruck und seine Komponenten. Ergeb. Physiol. 41, 292–606 (1939)Google Scholar
  110. Widimsky, J., Fejfarová, M.H., Feijfar, Z.: Changes of cardiac output in hypertensive disease. Cardiologia 31, 381–389 (1957)PubMedGoogle Scholar
  111. Widimsky, J., Feijfarová, M.H., Feijfar, Z., et al.: Der jugendliche Hochdruck. Arch. Kreislaufforsch. 28, 100–124 (1958)PubMedGoogle Scholar

Copyright information

© Springer-Verlag Berlin · Heidelberg 1978

Authors and Affiliations

  • Stevo Julius
    • 1
  1. 1.Division of Hypertension, Department of Internal MedicineUniversity of Michigan Medical SchoolAnn ArborUSA

Personalised recommendations